Skip to main content

Table 2 Adolescent’s biochemical profile, according to BMI

From: Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study

  HW (n = 77) OV (n = 82) OB (n = 83) P
TC, mg/dL 143 (32.1) 140 (34.3) 142 (39.8) 0.864
LDL-C, mg/dL 86 (33.5) 85 (35.6) 89 (40.1) 0.800
HDL-C, mg/dL 42 (13.5) 37 (13.3)* 35 (12.6)* <0.001
TG, mg/dL 75 (29.7) 87 (49.7) 91 (45.1)* 0.07
TG/HDL-C 1.90 (0.86) 2.69 (1.98)* 3.07 (2.24)* 0.001
TC/HDL-C 3.67 (1.39) 4.02 (1.72) 4.59 (2.16)* 0.021
LDL-C/HDL-C 1.81 (0.52) 1.90 (0.90) 1.79 (0.71) 0.051
Non HDL-C 100.9 (33.9) 102.6 (38.3) 107.1 (43.2) 0,575
Apo AI, mg/dL 120.9 (18.0) 113.7 (19.6) 109.1 (21.2)* 0.001
Apo B, mg/dL 62.8 (10.6) 65.2 (15.8) 65.2 (17.5) 0.533
Apo B/Apo AI 0.53 (0.12) 0.60 (0.15) 0.61 (0.16)* 0.003
LDL-C/ApoB 1.38 (0.4) 1.33 (0.48) 1.37 (0.53) 0.810
HDL-C/ApoA 0.35 (0.09) 0.33 (0.12) 0.32 (0.10) 0.122
LDL (−), mg/mL 8.9 (5) 10.8 (4.9) 10.5 (5.2) * 0.042
Anti LDL(−), mg/mL 8.5 (2.6) 7.5 (2.7)* 7.2 (3.0)* 0.010
HDL size, nm 10.8 (2.7) 10.8 (2.3) 10.9 (3.2) 0.638
Glucose, mg/dL 79.3 (12.8) 78.0 (12.5) 82.0 (13.2) 0.130
Insulin, uU/mL 15.3 (7.1) 19.8 (8.2)* 25.9 (14.5)*;** <0.001
HOMA-IR 3.0 (1.5) 3.9 (2.0)* 5.3 (3.1)*;** <0.001
  1. HW, healthy weight; OV, overweight; OB, obese; BMI, Body Mass Index; WC, waist circumference, HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein.
  2. Results were described as mean (standard deviation). *P < 0.05 vs HW group. **P < 0.05 vs OV group.